Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.250
+0.010 (0.81%)
At close: Nov 22, 2024, 4:00 PM
1.270
+0.020 (1.59%)
After-hours: Nov 22, 2024, 7:58 PM EST
BCLI Employees
Brainstorm Cell Therapeutics had 29 employees as of December 31, 2023. The number of employees decreased by 14 or -32.56% compared to the previous year.
Employees
29
Change (1Y)
-14
Growth (1Y)
-32.56%
Revenue / Employee
n/a
Profits / Employee
-$490,621
Market Cap
7.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
Syra Health | 162 |
Zhongchao | 142 |
Healthcare Triangle | 31 |
Addex Therapeutics | 23 |
Plus Therapeutics | 20 |
BioCardia | 20 |
ABVC BioPharma | 19 |
BCLI News
- 8 days ago - BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 11 days ago - BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing - PRNewsWire
- 23 days ago - BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 25 days ago - BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting - PRNewsWire
- 6 weeks ago - BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit - PRNewsWire
- 2 months ago - BrainStorm Cell Therapeutics Announces Presentations on NurOwn® at 2024 Annual NEALS Meeting - PRNewsWire
- 3 months ago - Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire